RIASTAP
Google image searchProduct monograph
Active ingredient
fibrinogen (human), 1000 MG/VIAL
DIN: 02393352
Dosage form(s): POWDER FOR SOLUTION
Route(s) of administration: INTRAVENOUS
Description: 900-1300 MG FIBRINOGEN /VIAL (20MG/ML AFTER REC.). SINGLE-USE VIALS
Schedule: Schedule D
Company: CSL BEHRING CANADA INC
Date: 31-JAN-2013
ATC:
- B02 — ANTIHEMORRHAGICS (ATC, ATC/DDD, )
- B02B — VITAMIN K AND OTHER HEMOSTATICS (ATC, ATC/DDD)
- B02BB — Fibrinogen (ATC, ATC/DDD)
- B02BB01 — FIBRINOGEN, HUMAN (ATC/DDD)
Reference brand drug: Fibryga, Riastap
